Business Standard

Alembic acquires 100% stake in Aleor Dermaceuticals from JV partner

The move is aimed at strengthening its skin-related manufacturing and marketing footprint

Alembic Pharmaceuticals ups its US game plan, acquires Orit
Premium

Alembic Pharmaceuticals

Sohini Das Mumbai
Vadodara based Alembic Pharmaceuticals has acquired the balance 40 per cent stake in Aleor Dermaceuticals from its joint venture partner Orbicular Pharma for an undisclosed sum. The move is aimed at strengthening its skin-related manufacturing and marketing footprint.

Alembic stock was down 0.1 percent today on BSE.

Aleor has product offerings across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, Microsponge and Nanoparticulate platform-based products.

The acquisition will help Alembic to secure higher market share in various segments where Aleor operates. Alembic thinks dermatology is a promising area and having 100 percent control over Aleor’s operations will enable it to

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 29 2022 | 3:59 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com